As of 2025-06-30, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (84.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.76 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -1183.1%.
The range of the Relative Valuation is (71.00) - (84.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 28.0x | 25.1x |
| Forward P/E multiples | 23.4x - 39.6x | 30.4x |
| Fair Price | (71.00) - (84.87) | (84.05) |
| Upside | -1014.9% - -1193.7% | -1183.1% |
| Date | P/E |
| 2025-06-27 | -2.56 |
| 2025-06-26 | -2.56 |
| 2025-06-25 | -2.61 |
| 2025-06-24 | -2.59 |
| 2025-06-23 | -2.50 |
| 2025-06-20 | -2.53 |
| 2025-06-18 | -2.69 |
| 2025-06-17 | -2.75 |
| 2025-06-16 | -2.89 |
| 2025-06-13 | -2.84 |
| 2025-06-12 | -2.95 |
| 2025-06-11 | -2.96 |
| 2025-06-10 | -2.98 |
| 2025-06-09 | -2.89 |
| 2025-06-06 | -3.00 |
| 2025-06-05 | -2.89 |
| 2025-06-04 | -2.99 |
| 2025-06-03 | -2.96 |
| 2025-06-02 | -2.89 |
| 2025-05-30 | -2.85 |
| 2025-05-29 | -2.87 |
| 2025-05-28 | -2.59 |
| 2025-05-27 | -2.58 |
| 2025-05-23 | -2.58 |
| 2025-05-22 | -2.60 |
| 2025-05-21 | -2.60 |
| 2025-05-20 | -2.61 |
| 2025-05-19 | -2.55 |
| 2025-05-16 | -2.48 |
| 2025-05-15 | -2.39 |
| 2025-05-14 | -2.35 |
| 2025-05-13 | -2.52 |
| 2025-05-12 | -2.61 |
| 2025-05-09 | -2.49 |
| 2025-05-08 | -2.57 |
| 2025-05-07 | -2.54 |
| 2025-05-06 | -2.59 |
| 2025-05-05 | -2.73 |
| 2025-05-02 | -2.90 |
| 2025-05-01 | -2.81 |
| 2025-04-30 | -2.73 |
| 2025-04-29 | -2.61 |
| 2025-04-28 | -2.56 |
| 2025-04-25 | -2.69 |
| 2025-04-24 | -2.69 |
| 2025-04-23 | -2.77 |
| 2025-04-22 | -2.76 |
| 2025-04-21 | -2.67 |
| 2025-04-17 | -2.60 |
| 2025-04-16 | -2.51 |